Janssen Takes A Step Closer To A Universal Flu Vaccine

Scientists at Janssen (Johnson & Johnson, formerly Crucell Vaccine Institute) have found a way to induce antibodies that could lead to the development of an effective universal flu vaccine and eliminate the need for annual injections.

Scientists at Janssen (Johnson & Johnson, formerly Crucell Vaccine Institute) have found a way to induce antibodies that could lead to the development of an effective universal flu vaccine and eliminate the need for annual injections.

Previous research has shown that some people can produce antibodies that can protect against many subtypes of influenza because they...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category